ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Amgen Inc

Amgen Inc (0R0T)

288,50
0,00
( 0,00% )
Aktualisiert: 10:17:38

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
288,50
Gebot
275,50
Fragen
303,00
Volumen
0,00
0,00 Tagesbereich 0,00
263,00 52-Wochen-Bereich 339,00
Marktkapitalisierung
Handelsende
288,50
Handelsbeginn
-
Letzte Trade
2
@
289.19
(O)
Letzter Handelszeitpunkt
21:57:17
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
7.812
Ausgegebene Aktien
535.178.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
23,10
Gewinn pro Aktie (EPS)
12,55
Erlöse
28,19B
Nettogewinn
6,72B

Über Amgen Inc

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Amgen Inc is listed in the Biological Pds,ex Diagnstics sector of the Londoner Börse with ticker 0R0T. The last closing price for Amgen was US$288,50. Over the last year, Amgen shares have traded in a share price range of US$ 263,00 to US$ 339,00.

Amgen currently has 535.178.000 shares in issue. The market capitalisation of Amgen is US$154,40 billion. Amgen has a price to earnings ratio (PE ratio) of 23.10.

0R0T Neueste Nachrichten

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition PR Newswire Reykjavik, ICELAND, Nov. 6, 2023 Reykjavik, ICELAND, Nov. 6, 2023 /PRNewswire/ -- A...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 06 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...

Drugmakers agree to US government price talks amid pushback

Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesda ...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 02 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-39.5-12.0426829268328328280.512522294.18188098DE
4-29-9.13385826772317.5328280.55850307.74295471DE
12-44-13.2330827068332.5337.25280.57812320.90951694DE
26-25.25-8.04780876494313.75339280.56753323.02255324DE
5225.59.6958174904926333926320330300.77434227DE
15684.541.421568627520433920222409259.55994872DE
26059.7526.1202185792228.75339185.2615287255.30032401DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SLFRSlf Realisation Fund Limited
1,49p
(29,57%)
17,64k
FARFerro-alloy Resources Limited
8,20p
(26,15%)
9,28M
NWORNational World Plc
18,50p
(23,33%)
128,75k
MASTMast Energy Developments Plc
0,16p
(18,52%)
16,63M
GAWGames Workshop Group Plc
13.380,00p
(14,26%)
28,01k
WEBWebis Holdings Plc
0,15p
(-62,50%)
10,61M
AMGOAmigo Holdings Plc
0,525p
(-16,67%)
6,7M
INDIIndus Gas Limited
7,65p
(-12,57%)
213,63k
OPTIOptibiotix Health Plc
11,00p
(-10,20%)
359,53k
CELCeladon Pharmaceuticals Plc
12,50p
(-9,09%)
13,3k
VELAVela Technologies Plc
0,0075p
(0,00%)
108,25M
NTOGNostra Terra Oil And Gas Company Plc
0,023p
(-3,16%)
91,32M
MSMNMosman Oil And Gas Limited
0,04p
(-2,44%)
74,49M
TRPTower Resources Plc
0,0275p
(-1,79%)
62,41M
CPXCap-xx Limited
0,13p
(1,96%)
26,69M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock